| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/26/2006 | US20060020117 Partial extraction of the antithrombin during the fractionation of human plasma so that the final albumin has an active antithrombin content equal to or greater than 0.03 mg/g of albumin |
| 01/26/2006 | US20060020116 Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules |
| 01/26/2006 | US20060020115 Given amino acid sequence; testing substance's ability to interact with complex; mutants used in crop protection and/or soil treatment |
| 01/26/2006 | US20060020114 Apo-2DcR |
| 01/26/2006 | US20060020113 Human Six Transmembrane Epithelial Antigen of the Prostate (STEAP) protein; folds in a "serpentine" manner into three extracellular and two intracellular loops; used for diagnosis and treatment of prostate cancer |
| 01/26/2006 | US20060020112 polynucleotide encoding coiled-coil domain of the Stat protein and the first three-strands of the DNA-binding domain of the Stat protein; cell expressing said polynucleotide |
| 01/26/2006 | US20060020110 Synthetic peptides that bind to the hepatitis B virus core and E antigens |
| 01/26/2006 | US20060020109 Synthetic peptides to treat an autoimmune demylinating disease e.g., multiple sclerosis; an amino acid sequence having two tyrosine residues and a lysine complex with the myelin basic protein to modulate an immune response |
| 01/26/2006 | US20060019924 used in neuroblastoma therapy and diagnosis |
| 01/26/2006 | US20060019914 Inhibition of tumor growth and invasion by anti-matrix metalloproteinase DNAzymes |
| 01/26/2006 | US20060019902 PTH-like peptides |
| 01/26/2006 | US20060019899 EphA2 T-cell epitopes and uses therefor |
| 01/26/2006 | US20060019897 Anti-angiogenic polypeptides |
| 01/26/2006 | US20060019893 Factor VIIa variants |
| 01/26/2006 | US20060019892 Conopeptides and methods of use |
| 01/26/2006 | US20060019888 such as viral myocarditis (Coxsackie virus, echovirus, polio virus) or dilated (congestive) cardiomyopathy, by binding ErbB2-ErbB4 receptors; atpase inhibitors |
| 01/26/2006 | US20060019887 Compositions and methods for the prevention or treatment of cancer and bone loss associated with cancer |
| 01/26/2006 | US20060019886 Monomer protein with bone morphogenetic activity and medicinal agent containing the same for preventing and treating diseases of cartilage and bone |
| 01/26/2006 | US20060019885 Modified bryodin 1 with reduced immunogenicity |
| 01/26/2006 | US20060019884 Peptide composition |
| 01/26/2006 | US20060019882 Use of Yops as caspase inhibitor |
| 01/26/2006 | US20060019881 Human spasmolytic polypeptide in glycosylated form |
| 01/26/2006 | US20060019879 Polynucleotide encoding autoantigens associated with endometriosis |
| 01/26/2006 | US20060019878 Polynucleotide encoding autoantigens associated with endometriosis |
| 01/26/2006 | US20060019877 Hasylated polypeptides |
| 01/26/2006 | US20060019874 Cation complexes of insulin compund conjugates, formulation and uses thereof |
| 01/26/2006 | US20060019873 treating insulin deficiencies or otherwise supplementing insulin in a subject using the insulin compound conjugates, cation-insulin compound conjugate complexes, and/or formulations of the invention; diabetes; improved oral bioavailability |
| 01/26/2006 | US20060019871 Endothelial cell apoptosis induced by fibrinogen gamma chain C-terminal fragment |
| 01/26/2006 | US20060019393 Minimal lentiviral vector system |
| 01/26/2006 | US20060019392 Novel bone mineralization proteins, DNA, vectors, expression systems |
| 01/26/2006 | US20060019386 Protein domain related to deafness, osteoarthritis and abnormal cell proliferation |
| 01/26/2006 | US20060019382 Transcriptionally-activated AAV inverted terminal repeats (ITRs) for use with recombinant AAV vectors |
| 01/26/2006 | US20060019370 Phage-resistant microorganisms and genetic determinants of phage resistance |
| 01/26/2006 | US20060019357 Nucleotide sequences which code for the rpsL gene |
| 01/26/2006 | US20060019356 Polynucleotides encoding polypeptides involved in intermediates metabolism of the central metabolic pathway in Methylophilus methylotrophus |
| 01/26/2006 | US20060019355 L-Amino acid-producing microorganism and method for producing L-amino acid |
| 01/26/2006 | US20060019352 Methods of increasing the production of cobalamins using cob gene expression |
| 01/26/2006 | US20060019351 Enhanced secretion of a polypeptide by a microorganism |
| 01/26/2006 | US20060019350 Recombinant negative strand RNA virus expression system and vacccines |
| 01/26/2006 | US20060019349 Position dependent recognition of GNN nucleotide triplets by zinc fingers |
| 01/26/2006 | US20060019348 Method of mass producing silk protein and gene recombinant silk-like protein with added functionality |
| 01/26/2006 | US20060019347 Biosynthetic polypeptides utilizing non-naturally encoded amino acids |
| 01/26/2006 | US20060019346 Identification of a novel bitter taste receptor T2R76 that specifically responds to brucine and prop bitter ligands |
| 01/26/2006 | US20060019345 Human GABAb receptor 1 promoters |
| 01/26/2006 | US20060019344 C-erbB-2 external domain: gp75 |
| 01/26/2006 | US20060019343 Pichia methanolica secretory signal |
| 01/26/2006 | US20060019339 Measurement of bioactive hepcidins |
| 01/26/2006 | US20060019338 Primate prokineticin and prokineticin receptor polypeptides, related compositions and methods |
| 01/26/2006 | US20060019336 Factor VII or VIIa - like molecules |
| 01/26/2006 | US20060019322 Nucleotide sequence coding polypeptide for use in diagnosis and therapy of prostate cancer |
| 01/26/2006 | US20060019318 Conformational and topological protein regulation |
| 01/26/2006 | US20060019316 Apparatus and method for automated protein design |
| 01/26/2006 | US20060019310 Cell regulatory genes, encoded products, and uses related thereto |
| 01/26/2006 | US20060019308 CD38 modulated chemotaxis |
| 01/26/2006 | US20060019307 Interleukin-8 homologous polypeptides and therapeutic uses thereof |
| 01/26/2006 | US20060019305 Diagnosis and treatment of PTP related disorders |
| 01/26/2006 | US20060019296 Methods of indentifying modulators of the FGF receptor |
| 01/26/2006 | US20060019294 Tyrosine kinase substrate (Tks) proteins |
| 01/26/2006 | US20060019293 Mutations of the 5' region of the human 5-HT1A gene, associated proteins of the 5' region and a diagnostic test for major depression and related mental illnesses |
| 01/26/2006 | US20060019287 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/26/2006 | US20060019281 Gene for which is located on the short arm of human chromosome 1; gene is directly implicated in colon, kidney and breast cancers |
| 01/26/2006 | US20060019275 Nucleic acids encoding proteins involved in sensory transduction |
| 01/26/2006 | US20060019271 Submergence-induced protein-like factors |
| 01/26/2006 | US20060019261 RNA-binding protein |
| 01/26/2006 | US20060019252 Genes and polypeptides relating to hepatocellular or colorectal carcinoma |
| 01/26/2006 | US20060019250 Method for the detection of carcinoembryonic agent and cancer diagnosis method based thereon |
| 01/26/2006 | US20060019249 Diagnostic conjugate useful for intracellular imaging and for differentiating between tumor-and non-tumor cells |
| 01/26/2006 | US20060019248 mutant SH3-binding protein (SH3BP2) nucleic acids, polypeptides, and agents which selectively bind to the mutant SH3BP2 molecules and which do not bind to the wild type SH3BP2 molecules |
| 01/26/2006 | US20060019241 Na+ and CI-coupled transport system for endogenous opioid peptides |
| 01/26/2006 | US20060018932 Recombinant protein containing a C-terminal fragment of Plasmodium MSP-1 |
| 01/26/2006 | US20060018929 Protein kinase deficient, immunologically active CMVpp65 mutants |
| 01/26/2006 | US20060018928 Virus-like particle containing a dengue virus recombinant replicon |
| 01/26/2006 | US20060018925 Compositions and methods for modulating RSV infection and immunity |
| 01/26/2006 | US20060018923 A nucleotide sequence along with the deduced amino acid sequences of the complete genomic sequence of a novel human coronavirus (CoV-HKU1) of the order Nidovirales; single-stranded RNA virus of positive polarity; immunogenic/vaccine preparations using recombinant and chimeric forms; vectors; cells |
| 01/26/2006 | US20060018920 Lawsonia derived gene and related OmpH polypeptides, peptides and proteins and their uses |
| 01/26/2006 | US20060018919 Peptide mimotopes of lipooligosaccharide from nontypeable Haemophilus influenzae as vaccines |
| 01/26/2006 | US20060018917 Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancers |
| 01/26/2006 | US20060018916 Compositions and methods for eliciting an immune response to gram-negative bacterial infections |
| 01/26/2006 | US20060018915 Heteroclitic analogs and related methods |
| 01/26/2006 | US20060018914 Novel antibody conjugates reactive with human carcinomas |
| 01/26/2006 | US20060018912 Snares for pathogenic or infectious agents and uses related thereto |
| 01/26/2006 | US20060018906 monoclonal antibody for treating cancer, neovascularization, vascular and arthritic diseases; immunoassay; immunotherapy; inhibition or antagonism of TNF decreases expression of Vascular Endothelial Growth Factor (VEGF) or Vascular Permeability Factor (VPF); decrease angiogenesis |
| 01/26/2006 | US20060018905 Methods for treating systemic lupus erythematosus using anti-TNF antibodies and fragments thereof |
| 01/26/2006 | US20060018896 Methods for treating conditions associated with lectin-dependent complement activation |
| 01/26/2006 | US20060018895 Murine monoclonal anti-idiotype antibody 11D10 and methods of use thereof |
| 01/26/2006 | US20060018892 nucleic acid molecule comprising nucleotide sequences, that code fro single chain proteins which are serine protease inhibitors, used for prophylaxis of emphysema, cirrhosis, hepatitis, blood disorders, tumors and tumor metastasis |
| 01/26/2006 | US20060018881 Coordinate in vivo gene expression |
| 01/26/2006 | US20060018873 inducing in a patient, at least one activity of IL-2 selected from increasing humoral immune responses and increasing cellular immune responses, by administering to said patient a therapeutically effective amount of a peptide sufficient to induce the activity |
| 01/26/2006 | US20060018831 TF binding agent and use thereof |
| 01/26/2006 | DE10393884T5 Zur Herstellung von Proteinen in chemisch definierten Medien nützliche klonale Myelom-Zellinien For the production of proteins in chemically defined media useful clonal myeloma cell lines |
| 01/26/2006 | CA2847655A1 Brassica indehiscent1 sequences |
| 01/26/2006 | CA2612303A1 Anti-glycated cd59 antibodies and uses thereof |
| 01/26/2006 | CA2574665A1 Therapeutic and diagnostic agents |
| 01/26/2006 | CA2574540A1 Cell cycle reporting cell line comprising phosphorylated subcellular localization domain (psld) of human dna helicase b (hdbd) |
| 01/26/2006 | CA2574530A1 Cell cycle phase markers comprising phosphorylated subcellular localization domain (psld) of human dna helicase b (hdhb) |
| 01/26/2006 | CA2574449A1 Variants of group 1 allergens from poaceae having reduced allergenicity and maintained t-cell reactivity |
| 01/26/2006 | CA2574224A1 Molecular diagnostic method and treatment in dementia with lewy bodies |
| 01/26/2006 | CA2574179A1 Detection of cellular stress |
| 01/26/2006 | CA2573786A1 Rgmc modified transgenic animals |
| 01/26/2006 | CA2573780A1 Recombinant spider silk proteins |